Carmona Jose Insider Trades

Insider Trading History

Track insider trading activity for Carmona Jose. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Financial Officer
Holding Value $2.26M 734,376 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$103k 25,880 shares
$3.99
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Financial Officer
Holding Value $2.34M 760,256 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 271,600 shares
$3.99
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Financial Officer
Holding Value $1.51M 488,656 shares
Last Trade
Dec 06, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$175k 53,236 shares
$3.29
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Financial Officer
Holding Value $1.67M 541,892 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$386k 240,000 shares
$1.61
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Financial Officer
Holding Value $930k 301,892 shares
Last Trade
Dec 06, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$151k 48,108 shares
$3.13
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Financial Officer
Holding Value $1.08M 350,000 shares
Last Trade
Jan 02, 2024 Sale
$777k 460,000 shares
$1.69
$3.08
Rubius Therapeutics
Rubius Therapeutics RUBY
Chief Financial Officer
Holding Value $8.19k 143,750 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$970k 143,750 shares
$6.75
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Chief Financial Officer
Holding Value $22.8k 400,000 shares
Last Trade
Nov 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.51M 400,000 shares
$6.27
$0.06
Radius Recycling
Radius Recycling RDUS
Chief Financial Officer
Holding Value $1.4M 46,708 shares
Last Trade
Feb 26, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$23.2k 1,292 shares
$17.93
$30.00
Radius Recycling
Radius Recycling RDUS
Chief Financial Officer
Holding Value $1.44M 48,000 shares
Last Trade
Feb 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5M 75,000 shares
$19.96
$30.00
Radius Recycling
Radius Recycling RDUS
Chief Financial Officer
Holding Value $1.65M 55,000 shares
Last Trade
Feb 22, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.34M 70,000 shares
$19.18
$30.00
Radius Recycling
Radius Recycling RDUS
Chief Financial Officer
Holding Value $1.8M 60,000 shares
Last Trade
Feb 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.27M 60,000 shares
$37.83
$30.00
Radius Recycling
Radius Recycling RDUS
Chief Financial Officer
Holding Value $90k 3,000 shares
Last Trade
Sep 14, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$98.5k 3,000 shares
$32.83
$30.00
Radius Recycling
Radius Recycling RDUS
Chief Financial Officer
Holding Value $3.75M 125,000 shares
Last Trade
May 15, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.37M 125,000 shares
$34.96
$30.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up